toxoidum diphtheriae ≥ 2 U.I., toxoidum tetani ≥ 20 U.I., toxoidum pertussis 8 µg, haemagglutininum filamentosum von Bordetella pertussis 8 µg, pertactinum von Bordetella pertussis 2.5 µg, virus poliomyelitis typus 1 inactivatus 40 U., virus poliomyelitis typus 2 inactivatus 8 U., virus poliomyelitis typus 3 inactivatus 32 U., natrii chloridum corresp. natrium 1.8 mg, aluminium 0.5 mg ut aluminii hydroxidum hydricum ad adsorptionem et aluminii phosphas, medium 199, aqua ad iniectabile q.s. ad suspensionem pro 0.5 ml, residui: neomycini sulfas, polymyxini B sulfas, polysorbatum 80, formaldehydum.
Packungsbestandteile
Active Agent
Vaccinum Diphtheriae Adsorbatum
Vaccinum Pertussis Acell. Adsorbatum
Vaccinum Poliomyelitidis Inactivatum (Salk typ I, II, III)
Vaccinum Tetani Adsorbatum
BAG: Active Agent
Dose
Toxoidum Diphtheriae
2 UI
Toxoidum Pertussis
8 mcg
Toxoidum Tetani
20 UI
Vaccinum Poliomyelitidis Inactivatum (Salk typ I, II, III)
80 U
Source
Data was imported : 05.01.2024
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
